SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Sigmund Freud — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSigmund Freud
Date of birth1856-05-06
IdentifiersMRN HR-ET005-SYN-TD; SSN (made up) 000-05-8403
Document date1930-10-26
AuthorAnton Reinholt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Five-month review: abstinence, screening results, pain and weight. [S]

History of Present Illness

Mr. Freud returns about five months after intake and four weeks after his wellness visit. He has not smoked for fourteen weeks. He takes varenicline 1 mg twice daily and two or three lozenges a day, and the patch was stopped at the wellness visit as planned. He has no muscle aches on atorvastatin 20 mg. The Candida stomatitis has not returned since he began cleaning the obturator nightly and leaving it out at night. His low-dose CT of the chest two weeks ago showed a 4 mm nodule (Lung-RADS 2), mild emphysema and coronary artery calcification; the aortic ultrasound was normal. He has no cough or breathlessness. His pain is 2 of 10, and he has stopped the nutrition supplements because he eats well. [S]

ElementDetail
TobaccoNo smoking for fourteen weeks; varenicline continues; two or three lozenges a day
Low-dose CTLung-RADS 2; mild emphysema; coronary calcification
Aortic ultrasound2.7 cm, normal
Atorvastatin20 mg daily for four weeks; no muscle aches
Pain2 of 10

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up; energy good
Ears, nose, mouth, and throatNegativeNo sore, lump, bleeding or nasal leakage
RespiratoryNegativeNo cough, breathlessness or blood in sputum
MusculoskeletalNegativeNo muscle aches
PsychiatricNegativeMood steady; occasional brief cravings

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four daysOne tablet daily for three days, then twice daily for four days, after foodOral route1930-06-01 to 1930-06-08completedS
Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeksOne tablet twice daily after foodOral route1930-06-08activeS
Nicotine 21 mg/24 hours transdermal patch, one patch each morning from the quit date, for six weeksOne patch each morningTopical route1930-07-20 to 1930-08-31completedS
Nicotine 14 mg/24 hours transdermal patch, one patch each morning for four weeks, then stopOne patch each morningTopical route1930-08-31 to 1930-09-28completedS
Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesisOne lozenge as needed, up to 10 a dayOral route1930-07-20activeS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy siteTwo tablets three times dailyOral route1930-06-01activeS
Nystatin 100,000 units/mL oral suspension, 5 mL swished around the mouth and defect for as long as possible and then swallowed, four times daily with the obturator out, for 14 days5 mL four times daily for 14 daysOral route1930-09-14 to 1930-09-28completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1930-09-28activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1930-10-26Body height172cmS
1930-10-26Body weight60.6kgS
1930-10-26Body mass index (BMI) [Ratio]20.5kg/m2S
1930-10-26Systolic blood pressure130mm[Hg]S
1930-10-26Diastolic blood pressure78mm[Hg]S
1930-10-26Heart rate68/minS
1930-10-26Respiratory rate14/minS
1930-10-26Body temperature36.6CelS
1930-10-26Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1930-10-26Hemoglobin [Mass/volume] in Blood13.8g/dL13.5-17.5 g/dLNormalS
1930-10-26MCV [Entitic mean volume] in Red Blood Cells by Automated count92fL80-100 fLNormalS
1930-10-26Albumin [Mass/volume] in Serum or Plasma3.9g/dL3.5-5 g/dLNormalS
1930-10-26Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
1930-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M81mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1930-10-26Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma25U/L7-55 U/LNormalS
1930-10-26Pain severity in the past week - 0-10 numeric rating [Reported]2{score}S

Physical Exam

Vital signs recorded on 1930-10-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 130/78, pulse 68; weight 60.6 kg
MouthMucosa healthy; no plaques, ulcer, mass or white or red patch; obturator clean and well fitting
NeckNo lymph nodes felt
RespiratoryClear to auscultation

Problems

ProblemClinical statusVerificationCodeProvenance
Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smokingactiveconfirmed F17.290S — Synthetic modern coding; person-first language; not a claim about his real diagnosis.
Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillanceactiveconfirmed Z85.818S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic.
Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorlyactiveconfirmed Z90.09S — Synthetic modern coding anchored to his documented obturator.
Hypernasal speech and nasal leakage of liquids from a poorly sealing obturatorresolvedconfirmed R49.21S — Synthetic finding; resolved when the new obturator was fitted.
Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubsactiveconfirmed G89.29S — Synthetic modern coding anchored to his documented constant mouth pain.
Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smokingactiveconfirmed E78.5S — Synthetic finding on the intake lipid panel.
Weight loss of 4 kg in six months from painful chewing and leakage, with a low albuminresolvedconfirmed R63.4S — Synthetic finding; resolved as weight and albumin recovered.
Candida stomatitis of the palate and defect under the new obturator; treated with nystatin and prosthesis hygiene; resolvedresolvedconfirmed B37.0S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyTobacco use (cigars a day), readiness and quit dateEvery visitCompleted todayNo smoking for fourteen weeks; exhaled carbon monoxide 3 ppm (narrative)
Medication safetyVarenicline adherence and side effects (nausea, sleep, dreams, mood)Every visit; at least 12 weeks, extended to 24 weeks or moreCompleted today1 mg twice daily; no side effects; to complete 24 weeks next month
Medication safetyCombination nicotine replacement (patch and lozenge)From the quit date for at least 8 to 12 weeksCompleted todayPatch finished after ten weeks; lozenges two or three a day, to taper
Self-managementBehavioral support (quitline and clinic sessions)Weekly calls around the quit date, then every two to four weeksCompleted todayQuitline every two weeks; final call next month
Self-managementRelapse preventionEvery visitCompleted todayNo slips since the second week
LaboratoryKidney function for varenicline dosingBaseline; again if illness or new medicinesCompleted todayCreatinine 0.98 mg/dL, eGFR 81
ExaminationHead and neck surveillance examination (mouth, defect and neck)Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visitCompleted todayMouth and neck normal today; surgeon's next yearly examination next summer
ImagingHead and neck imagingOnly for symptoms or signs more than five years after treatmentNot indicatedNo symptoms or signs
ImagingLung cancer screening eligibilityYearly low-dose CT when chosen by shared decisionCompleted todayLow-dose CT two weeks ago: Lung-RADS 2; next in 12 months
ExaminationObturator fit, seal and hygieneEvery visitCompleted todayObturator clean and well fitting; nightly cleaning and overnight removal continue
ExaminationSpeech and swallowing (hypernasality, nasal leakage)Every visit; speech-language therapy as neededCompleted todayTherapy course finished; normal resonance
Self-managementDental care (high-fluoride toothpaste, cleaning every three months)Daily toothpaste; cleaning every three monthsCompleted todayDental cleaning last month
ExaminationWeight and nutritionEvery visitCompleted today60.6 kg; supplements stopped
LaboratoryAlbuminBaseline and at three months while weight is recoveringCompleted todayAlbumin 3.9 g/dL; hemoglobin 13.8 g/dL, MCV 92 fL
LaboratoryALT and muscle symptoms on atorvastatinBaseline, then if symptomsCompleted todayALT 25 U/L; no muscle symptoms
SurveyPain score and functionEvery visitCompleted today2 of 10
Medication safetyAcetaminophen daily dose (no more than 3,000 mg)Every visitCompleted today3,000 mg a day; may move to as needed
Medication safetyOpioidsAvoid long-term opioidsNot indicatedNot needed

Goal progress:

Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Lung Cancer: Screening (2021)

Follow-up: Stop varenicline after 24 weeks next month. Review in three months with spirometry. Low-dose CT and the surgeon's examination yearly. Next wellness visit in one year. [S]